17 completed, 3 recruiting, 2 unknown, 1 enrolling by invitation. 25 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 25 | Completed 17, Recruiting 3, Unknown 2, Enrolling by invitation 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 2, Recruiting 2 |
Follow Somatosensory Disorders: new trials by email Literature Review of Somatosensory Disorders trials Research Report on Somatosensory Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia AXS-14 (esreboxetine) - Fibromyalgia | Phase 3 | Enrolling by invitation | Axsome Therapeutics, Inc. | 300 | 2026-04-29 | 2026-11-06 |
| Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design AXS-14 (Esreboxetine), Placebo - Fibromyalgia | Phase 3 | Recruiting | Axsome Therapeutics, Inc. | 620 | 2026-01-14 | 2026-11-10 |
| Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia | Phase 2 / Phase 3 | Recruiting | Bernardino Clavo, MD, PhD | 42 | 2025-02-07 | 2026-09-18 |
| Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544). Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia | Phase 2 / Phase 3 | Recruiting | Bernardino Clavo, MD, PhD | 42 | 2025-02-07 | 2026-09-25 |
| Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN Acetyllevocarnitine Hydrochloride Tablets, Placebo - Diabetic Peripheral Neuropathy (DPN), Paresthesia | Phase 3 | Completed | Haisco Pharmaceutical Group Co., Ltd. | 516 | 2020-07-23 | 2022-04-08 |
| Using Intranasal Midazolam (INM) and Lidocaine for Uncooperative Children Midazolam, Lidocaine-Midazolam, Placebo - Burning Nose | Phase 2 / Phase 3 | Completed | Latakia University | 63 | 2017-06-01 | 2018-11-05 |
| Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study Verum acupuncture - Colorectal Cancer | Phase 3 | Unknown | Tzu-Liang Chen | 32 | 2016-01-01 | 2016-04-21 |
| Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet Polyamines depleted diet, associating Polydol® cans and predefined menus low in polyamines - Neuropathy, Digestive Cancer System | Phase 3 | Completed | University Hospital, Clermont-Ferrand | 80 | 2013-02-02 | 2017-07-11 |
| Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache Botulinum toxin type A, 0,9% saline - Headache, Allodynia | Phase 3 | Completed | Federal University of Bahia | 40 | 2010-12-01 | 2011-05-23 |
| Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia Ketamine, Saline - Pain, Hyperalgesia | Phase 3 | Completed | Federal University of São Paulo | 60 | 2010-09-01 | 2014-11-10 |
| Effect of Opioids in Neuropathic Pain in Postherpetic Patients Remifentanil - Neuralgia, Postherpetic | Phase 3 | Unknown | Medical University of Vienna | 30 | 2010-08-01 | 2010-04-12 |
| Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia continuous ropivacaine preperitoneal infusion, intravenous lidocaine infusion, parenteral analgesia combining acetaminophen and morphine - Pain, Postoperative | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 95 | 2010-02-01 | 2014-01-22 |
| Local Anesthetic Infusion and Sternotomy Local anesthetic (Ropivacaine), Saline - Hyperalgesia, Pain | Phase 3 | Terminated | University Hospital, Bordeaux | 21 | 2009-02-01 | 2011-12-13 |
| Local Anesthetic Infiltration to Prevent Postoperative Pain After Lumbar Surgery Ropivacaine / Placebo - Hyperalgesia | Phase 3 | Completed | University Hospital, Bordeaux | 50 | 2009-01-01 | 2026-05-19 |
| Pain Medicine for Wound Care Procedures Morphine plus Ketamine, Morphine plus Saline (placebo) - Wound Care, Pain Intensity | Phase 3 | Completed | University of California, San Francisco | 12 | 2008-06-01 | 2024-03-26 |
| Epidural Clonidine for Postoperative Hyperalgesia Clonidine - Postoperative Hyperalgesia | Phase 3 | Withdrawn | Cambridge University Hospitals NHS Foundation Trust | 2007-12-01 | 2014-01-08 | |
| Effects of Nefopam on Hyperalgesia After Cardiac Surgery Nefopam, néfopam, Placebo comparator - Hyperalgesia, Pain, Postoperative | Phase 2 / Phase 3 | Completed | University Hospital, Bordeaux | 90 | 2006-12-01 | 2010-05-28 |
| Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures Phentolamine Mesylate (NV-101) - Anesthesia, Dental | Phase 3 | Completed | Novalar Pharmaceuticals, Inc. | 240 | 2006-02-01 | 2006-11-17 |
| Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures Phentolamine Mesylate (NV-101) - Anesthesia, Dental | Phase 3 | Completed | Novalar Pharmaceuticals, Inc. | 240 | 2006-02-01 | 2006-11-17 |
| Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. Xaliproden (SR57746A), Placebo, Oxaliplatin - Metastases, Colorectal Neoplasms | Phase 3 | Completed | Sanofi | 879 | 2005-12-01 | 2016-05-04 |
Showing 20 of 25. Sign in to see all of them.
Hyperalgesia (14) · Paresthesia (9) · Pain (8) · Hypesthesia (5) · Pain, Postoperative (4) · Colorectal Neoplasms (3) · Neoplasm Metastasis (3) · Neurotoxicity Syndromes (3) · Anxiety Disorders (2) · Depression (2) · Fibromyalgia (2) · Peripheral Nervous System Diseases (2) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchiolitis Obliterans Syndrome (1)
Nervous System Diseases (25) · Pathological Conditions, Signs and Symptoms (25) · Sensation Disorders (25) · Signs and Symptoms (25) · Neurologic Manifestations (24) · Pathologic Processes (8) · Neuromuscular Diseases (6) · Neoplasms by Site (5) · Digestive System Diseases (4) · Neoplasms (4) · Postoperative Complications (4) · Chemically-Induced Disorders (3) · Colonic Diseases (3) · Digestive System Neoplasms (3)
Sodium Chloride (3) · Ketamine (2) · Morphine (2) · Oxygen (2) · Phentolamine (2) · Ropivacaine (2) · esreboxetine (2) · xaliproden (2) · 2,2'-dithiodiethanesulfonic acid (1) · Anesthetics, Local (1) · Botulinum Toxins, Type A (1) · Clonidine (1) · Fentanyl (1) · Fluorouracil (1) · Leucovorin (1)
University Hospital, Bordeaux (3) · Axsome Therapeutics, Inc. (2) · Bernardino Clavo, MD, PhD (2) · Novalar Pharmaceuticals, Inc. (2) · Sanofi (2) · Assistance Publique - Hôpitaux de Paris (1) · BioNumerik Pharmaceuticals, Inc. (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Federal University of Bahia (1) · Federal University of São Paulo (1) · Haisco Pharmaceutical Group Co., Ltd. (1) · Jazz Pharmaceuticals (1) · Latakia University (1) · Medical University of Vienna (1) · National Center for Research Resources (NCRR) (1)
United States (6) · France (5) · Brazil (3) · Spain (3) · United Kingdom (3) · Argentina (1) · Australia (1) · Austria (1) · Canada (1) · Chile (1) · China (1) · Germany (1) · Hungary (1) · Italy (1) · Norway (1)
Athena Papas, DMD (2) · Bernardino Clavo, MD, PhD (2) · Anthony Absalom, MBBS MD FRCA (1) · Himar Fabelo, BSc, PhD (1) · Jacob Lorenzo-Morales, Prof (1)
PMID 30679026, PMID 31378656, PMID 36606664, PMID 10691234, PMID 10910490, PMID 12826855, PMID 15317861, PMID 15983467, PMID 16508405, PMID 18806023, PMID 21436683, PMID 23063945, PMID 24420962, PMID 25833669, PMID 27739142, PMID 41572235
2008 (1)